Eagle Pharmaceuticals, Inc.
Eagle Pharmaceuticals, Inc. (EGRX) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · EGRX · as of Jun 9, 2026
Key Statistics
Explore Eagle Pharmaceuticals, Inc. Data
egrx stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 6 · Buy rate: 33.3%
Competitors & Peers
egrx competitorsEGRX
BLMH
CLCFF
CNFHF
ECGS
MCUJFStock Performance
Full HistoryAbout Eagle Pharmaceuticals, Inc.
Eagle Pharmaceuticals, Inc. is a pharmaceutical firm primarily engaged in developing and bringing to market drug candidates for conditions affecting the central nervous system, metabolic critical care…
what is eagle pharmaceuticals, inc. · egrx stock overview · eagle pharmaceuticals, inc. company profile · who is eagle pharmaceuticals, inc. ceo · egrx OTC · eagle pharmaceuticals, inc. headquarters · eagle pharmaceuticals, inc. business segments
About Stock Overview & Key Data
Eagle Pharmaceuticals, Inc. (EGRX) is a Healthcare company in the Drug Manufacturers - Specialty & Generic industry, listed on OTC since Feb 12, 2014. As of the latest trading session, EGRX stock price is $0.60, with a market capitalization of $7.9M. The stock has returned -73.33% over the past 12 months and -14.29% year-to-date.
According to 6 Wall Street analysts, the consensus rating for Eagle Pharmaceuticals, Inc. stock is Hold, with an average 12-month price target of $—. In fiscal year 2022, Eagle Pharmaceuticals, Inc. reported revenue of $316.6M and net income of $35.6M. For detailed data — including Eagle Pharmaceuticals, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Eagle Pharmaceuticals, Inc. (EGRX) stock price is $0.60. The stock is traded on OTC under the ticker symbol EGRX. The 52-week range is $0.09 – $3.87.